We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.49%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.3B
AUM Growth
+$91M
Cap. Flow
-$6.54M
Cap. Flow %
-0.5%
Top 10 Hldgs %
34.31%
Holding
270
New
10
Increased
44
Reduced
91
Closed
6

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$1.24M
2
ON icon
ON Semiconductor
ON
+$940K
3
SYK icon
Stryker
SYK
+$884K
4
OGN icon
Organon & Co
OGN
+$748K
5
DE icon
Deere & Co
DE
+$623K

Sector Composition

Rank Sector Weight
1 Technology 20.7%
2 Healthcare 18.34%
3 Financials 15.25%
4 Industrials 11.71%
5 Communication Services 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADI icon
151
Analog Devices
ADI
$190B
$645K 0.05%
3,749
MO icon
152
Altria Group
MO
$114B
$630K 0.05%
13,225
+1,000
+8% +$49.1K
CERN
153
DELISTED
Cerner Corp
CERN
$628K 0.05%
8,040
KEYS icon
154
Keysight
KEYS
$58.3B
$612K 0.05%
3,964
SNA icon
155
Snap-on
SNA
$21.5B
$609K 0.05%
2,725
-125
-4% -$29.9K
MDLZ icon
156
Mondelez International
MDLZ
$79.9B
$608K 0.05%
9,731
+1,558
+19% +$96K
APD icon
157
Air Products & Chemicals
APD
$67.6B
$592K 0.05%
2,055
INTU icon
158
Intuit
INTU
$89B
$592K 0.05%
1,207
WAT icon
159
Waters Corp
WAT
$39.9B
$566K 0.04%
1,637
FLS icon
160
Flowserve
FLS
$10.2B
$565K 0.04%
14,005
ZBH icon
161
Zimmer Biomet
ZBH
$18.4B
$563K 0.04%
3,605
XBI icon
162
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$519K 0.04%
3,830
-1,750
-31% -$230K
CSCO icon
163
Cisco
CSCO
$479B
$506K 0.04%
9,532
HSIC icon
164
Henry Schein
HSIC
$9.82B
$499K 0.04%
6,724
-101
-1% -$7.61K
AEP icon
165
American Electric Power
AEP
$68.4B
$491K 0.04%
5,800
AVGO icon
166
Broadcom
AVGO
$2.04T
$484K 0.04%
10,150
AWK icon
167
American Water Works
AWK
$26.9B
$478K 0.04%
3,100
IAT icon
168
iShares US Regional Banks ETF
IAT
$681M
$460K 0.04%
8,000
+1,050
+15% +$62.3K
UTG icon
169
Reaves Utility Income Fund
UTG
$3.61B
$460K 0.04%
13,418
TDG icon
170
TransDigm Group
TDG
$67.7B
$450K 0.03%
695
OKE icon
171
Oneok
OKE
$54.5B
$445K 0.03%
8,000
SBUX icon
172
Starbucks
SBUX
$120B
$444K 0.03%
3,972
+40
+1% +$4.52K
LOW icon
173
Lowe's Companies
LOW
$125B
$443K 0.03%
2,286
MPC icon
174
Marathon Petroleum
MPC
$83.7B
$439K 0.03%
7,264
SAM icon
175
Boston Beer
SAM
$1.92B
$434K 0.03%
425

Similar funds

Neville Rodie & Shaw's Q2 2021 Portfolio in Review

As of Q2 2021, Neville Rodie & Shaw held 270 positions worth $1.3B, up 7.5% from $1.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Neville Rodie & Shaw's Q2 2021 filing shows 10 new, 44 increased, 91 reduced and 6 closed positions. Its largest new stake was Stryker: 3,458 shares worth $898K. The largest sale was Merck, an estimated $1.69M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q2 2021 buy was Stryker: 3,458 shares worth $898K.
  • Neville Rodie & Shaw added most to Morgan Stanley in Q2 2021, an estimated $1.24M increase.
  • Neville Rodie & Shaw's biggest Q2 2021 reduction was Merck, cutting an estimated $1.69M.
  • Neville Rodie & Shaw fully exited Veeva Systems in Q2 2021, selling an estimated $1.36M.
  • Neville Rodie & Shaw's ten largest holdings make up 34% of its $1.3B portfolio in Q2 2021.
  • Neville Rodie & Shaw opened 10 new positions and closed 6 in Q2 2021.
  • Neville Rodie & Shaw's portfolio value rose 7.5% quarter-over-quarter to $1.3B.

Based on Neville Rodie & Shaw's 13F filing for Q2 2021, filed 6 Jul 2021.